Clinical Report: Pathology Priorities 2026: The ASCP Vision
Overview
The ASCP's 2026 priorities focus on enhancing diagnostic quality, workforce development, and patient access amidst evolving regulatory landscapes. Key changes include the reversal of the FDA's laboratory-developed test rule, emphasizing the need for robust compliance and evidence standards.
Background
The American Society for Clinical Pathology (ASCP) plays a crucial role in shaping pathology practice and ensuring high-quality diagnostics. With recent regulatory changes impacting laboratory-developed tests, it is essential for the ASCP to lead in maintaining standards and access to testing. The focus on cancer biomarkers and digital pathology further underscores the need for updated guidelines and practices.
Data Highlights
No numerical data available in the source material.
Key Findings
['Gregory G. Davis, MD, MSPH, was installed as ASCP President for 2025–2026.', "The FDA's laboratory-developed test rule was reversed, impacting regulatory oversight.", 'ASCP aims to sustain patient access to high-quality diagnostics while strengthening compliance infrastructure.', 'CAP updated guidelines on HPV testing, emphasizing p16 immunohistochemistry as a surrogate for HPV status.', 'Digital pathology workflows are being standardized to enhance safety and data integrity.']Clinical Implications
Pathologists should stay informed about regulatory changes and adapt their practices to comply with updated guidelines. Emphasizing the use of standardized biomarkers and digital workflows can enhance diagnostic accuracy and patient care.
Conclusion
The ASCP's vision for 2026 highlights the importance of adapting to regulatory changes while ensuring high-quality diagnostic practices. Continued engagement in policy discussions will be vital for the future of pathology.
Related Resources & Content
- Gregory G. Davis, MD, MSPH, Installed as 2025–2026 President of the American Society for Clinical Pathology, ASCP, 2025 -- Pathology Priorities 2026: The ASCP Vision
- The ASCO Post — The Promise of Genomics
- The ASCO Post — Reflecting on the Past Year and Looking Ahead to the Next
- The ASCO Post — ASCO President-Elect Candidate Lynn M. Schuchter, MD, FASCO
- The ASCO Post — Oncologists, Pathologists Partner to Improve Practice and Optimize Patient Care
- Gregory G. Davis, MD, MSPH, Installed as 2025–2026 President of the American Society for Clinical Pathology
- Human Papillomavirus Testing in… | College of American Pathologists
- Platelet Transfusion: 2025 AABB and ICTMG International Clinical Practice Guidelines | Bleeding and Transfusion | JAMA | JAMA Network
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

About the Author(s)
Helen Bristow
Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.